Search

Issue
Title
Authors
Factors associated with a reduction in glomerular filtration rate in patients with chronic obstructive pulmonary disease
Bolotova E.V., Dudnikova A.V.
Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases
Fomin V.V., Pulin A.A., Mukhin N.A.
Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
Salukhov V.V., Shamkhalova M.S., Duganova A.V.
The agreed experts’ position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2
Arutiunov G.P., Tarlovskaia E.I., Koziolova N.A., Boldina M.V., Batiushin M.M., Ametov A.S., Arutiunov A.G., Belevskii A.S., Galstian G.R., Grigor’eva N.I., Dzhunusbekova G.A., Esaian A.M., Mal’chikova S.V., Mit’kovskaia N.P., Mkrtumian A.M., Orlova I.A., Petrova M.M., Rebrov A.P., Ruzanov D.I., Salukhov V.V., Sisakian A.S., Skibitskii V.V., Sugraliev A.B., Fomin I.V., Khalimov I.S., Chesnikova A.I., Shaposhnik I.I., Shestakova M.V.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E.L., Vaizova O.E., Meleshko M.V., Samoilova I.G., Podchinenova D.V., Borozinets A.A., Matveeva M.V., Kudlay D.A.
Resolution of the Expert Forum "New therapeutic horizons of NAFLD"
Drapkina O.M., Martynov A.I., Arutyunov G.P., Bakulin I.G., Livzan M.A., Maev I.V., Egorov I.V.
The role of chronic kidney disease in assessing the risk of the poor course of hospital ST-segment elevation myocardial infarction
Karetnikova V.N., Kalaeva V.V., Evseeva M.V., Osokina A.V., Kashtalap V.V., Gruzdeva O.V., Shafranskaya K.S., Zykov M.V., Barbarash O.L.
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M.V., Kotovskaya Y.V., Ivashkin V.T., Tkacheva O.N., Troshina E.A., Shestakova M.V., Breder V.V., Geyvandova N.I., Doshchitsin V.L., Dudinskaya E.N., Ershova E.V., Kodzoeva K.B., Komshilova K.A., Korochanskaya N.V., Mayorov A.Y., Mishina E.E., Nadinskaya M.Y., Nikitin I.G., Pogosova N.V., Tarzimanova A.I., Shamkhalova M.S.
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Shakhmatova O.O., Komarov A.L., Krivosheeva E.N., Dobrovolsky A.B., Titaeva E.V., Amelyushkina V.A., Gomyranova N.V., Panchenko E.P.
Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis
Chebotareva N.V., Gulyaev S.V., Androsova T.V., Popova E.N., Gurova D.V., Novikov P.I., Milovanova L.Y., Moiseev S.V.
Cystatin C and preclinical lesions in the target organs of hypertensive patients
Oshchepkova E.V., Dmitriev V.A., Titov V.N.
Hyperuricemia and kidney damage in patients with cardiovascular disease: A review
Mironova O.I.
Predictors of clinical events in patients with Fabry disease: the role of chronic kidney disease
Moiseev S.V., Karovaikina E.A., Bulanov N.M., Moiseev A.S., Fomin V.V.
Epidemiology of chronic renal disease in the Northwest of Russia: setting-up the register
Dobronravov V.A., Smirnov A.V., Dragunov S.V., Zverkov R.V., Evdokimova T.V., Butrimova S.S., Grigorschuk V.I.
Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial
Arutyunov G.P., Lopatin Y.M., Ametov A.S., Ageev F.T., Antsiferov M.B., Villevalde S.V., Vinogradova N.G., Galstyan G.R., Galyavich A.S., Gilyarevskiy S.R., Glezer M.G., Zhirov I.V., Ilyin M.V., Lebedeva A.I., Nedogoda S.M., Salukhov V.V., Tarlovskaya E.I., Tereshchenko S.N., Fomin I.V., Khalimov I.S., Khasanov N.R., Cherkashin D.V., Yakushin S.S.
Motivation for treatment in patients with chronic cardiorenal syndrome
Efremova E.V., Shutov A.M., Borodulina E.O.
Long-term outcomes and formation of chronic disease of the kidneys in patients with a history of hemorrhagic fever with renal syndrome
Dudarev M.V., Pimenov L.T.
Analysis of the course and outcomes of pregnancy in patients with advanced stages chronic kidney disease
Demyanova K.A., Kozlovskaya N.L., Korotchaeva Y.V., Apresyan S.V., Rylceva L.P., Usatenko G.V., Lugovoj A.O., Vorobyeva M.A., Bondarenko T.V., Bespalova A.V., Volkova O.A.
Phosphate binders in chronic kidney disease: The positions of sevelamer
Fomin V.V., Shilov E.M., Svistunov A.A., Milovanov I.S.
Diagnostic value of cystatin C and neutrophil gelatinase-associated lipocalin in primary glomerulopathies
Proletov I.I., Saganova E.S., Galkina O.V., Zubina I.M., Bogdanova E.O., Sipovskiĭ V.G., Smirnov A.V.
REMODELING OF CARDIOVASCULAR SYSTEM AND DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME AND OBESITY: ROLE OF GENES ENOS, SUBUNIT P22-PHOX OF NADPH-OXIDASE AND MTHFR
Saginova E.A., Gallyamov M.G., Balatsky A.V., Kolotvin A.V., Severova M.V., Samokhodskaya L.M., Fomin V.V., Krasnova T.N., Mukhin N.A.
Progressiveazotemia provoked by ACE inhibitor in renal ischemia
Fomin V.V., Taronishvili О.I., Shvetsov M.Y., Shilov E.M., Moiseev S.V., Kushnir V.V., Sorokin Y.D.
Chronic kidney disease and chronic heart failure: impact on prognosis and choice of pathogenetic therapy
Mezhonov E.M., Reitblat O.M., Vyalkina Y.A., Airapetian A.A., Lazareva N.V., Ageev F.T., Blankova Z.N., Svirida O.N., Prints Y.S., Zhirov I.V., Tereshchenko S.N., Boytsov S.A.
Circulating microRNAs as potential biomarkers of chronic kidney disease
Aitbaev K.A., Murkamilov I.T., Fomin V.V.
Adenoma of the parathyroid gland in a young woman with chronic kidney disease: primary or tertiary hyperparathyroidism?
Vetchinnikova O.N., Prokopenko E.I., Voronkova I.A.
Role of free radical oxidation in the development of cardiovascular events in chronic renal failure
Dzgoeva F.S., Gatagonova T.M., Dzugkoeva F.S., Kochisova Z.K., Kadzaeva Z.K., Khamitsaeva O.V., Dzgoyeva F.U., Gatagonova T.M., Dzugkoyeva F.S., Kochisova Z.K., Kadzayeva Z.K., Khamitsayeva O.V.
Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease
Rudenko T.E., Vasilyeva M.P., Solomakhina N.I., Kutyrina I.M.
Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease
Konenkov V.I., Klimontov V.V., Myakina N.E., Tyan N.V., Fazullina O.N., Romanov V.V.
Experience with active vitamin D metabolites in phosphorus-calcium metabolic disorders in patients with predialysis chronic kidney disease
Milovanova L.I., Dobrosmyslov I.A., Milovanov I.S.
MYOCARDIAL REMODELING RISK FACTORS AT STAGE II-IV CHRONIC KIDNEY DISEASE
Rudenko T.E., Kutyrina I.M., Shvetsov M.Y.
Hyperfiltration is an early sign of evolving chronic renal disease in males with metabolic syndrome
Novikova M.S., Shilov E.M., Borisov V.V., Novikova M.S., Shilov E.M., Borisov V.V.
Features of pregnancy after simultaneous pancreas-kidney transplantation in patient with type 1 diabetes mellitus. Case report
Yevloyeva M.I., Savitskaya D.U., Severina A.S., Shamkhalova M.S., Trubitsyna N.P., Shestakova M.V.
Anemia of chronic diseases in the early stages of chronic kidney disease as a risk factor for cardiovascular complications in patients with glomerulonephritis
Markina M.V., Milovanova L.Y., Lysenko L.V., Milovanova S.Y., Volkov A.V., Beketov V.D., Lebedeva M.V., Nezhdanov K.S., Moiseev S.V.
COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic
Zubkin M.L., Frolova N.F., Kim I.G., Ushakova A.I., Usatiuk S.S., Iskhakov R.T., Diakova E.N., Chervinko V.I., Volodina E.V., Tomilina N.A., Kryukov E.V.
Chronic kidney disease in the context of toxic effects the working chemical factors (literature review)
Strizhakov L.A., Fomin V.V., Garipova R.V., Babanov S.A., Arkhipov E.V., Lebedeva M.V.
Nonglycemic effects of incretins in patients with long-term type 1 diabetes mellitus and chronic kidney disease
Arutyunova M.S., Glazunova A.M., Mikhaleva O.V., Zuraeva Z.T., Martynov S.A., Klefortova I.I., Manchenko O.V., Ulyanova I.N., Ilyin A.V., Shamkhalova M.S., Shestakova M.V.
Prognostic value of renal resistance index in estimating the progression of chronic kidney disease
Gazhonova V.E., Zykova A.S., Chistyakov A.A., Roshchupkina S.V., Romanova M.D., Krasnova T.N.
Efficiency and safety of lipid-lowering therapy for chronic kidney disease
Kolina I.B., Stavrovskaia E.V.
Experience with ebrantil used in patients with resistant arterial hypertension in chronic kidney disease
Semenova R.I., Musina N.S.
Current methods for measuring the glomerular filtration rate in persons with normal weight and overweight
Novikova M.S., Kutyrina I.M., Shilov E.M., Novikova M.S., Kutyrina I.M., Shilov E.M.
Frailty and chronic kidney disease – the real problem of modern nephrology: A review
Rudenko T.E., Bobkova I.N., Kamyshova E.S., Stavrovskaya E.V.
Chronic kidney disease as a multidisciplinary problem of contemporary medicine
Podzolkov V.I., Bragina A.E.
Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease
Milovanova L.I., Milovanov I.S., Kozlovskaia L.V., Mukhin N.A.
Test strip evaluation of albuminuria for the early detection of chronic kidney disease in persons at different risks (the experience of the Health Centers of the Moscow Region)
Nagaĭtseva S.S., Shaliagin I.D., Shvetsov M.I., Piagaĭ N.L., Ivanova E.S., Shilov E.M.
The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review
Bobkova I.N.
Prevalence, age and gender features of chronic kidney disease in patients with diabetes mellitus
Murkamilov I.T., Aitbaev K.A., Fomin V.V.
Renal experiences of bariatric surgery in patients with type 2 diabetes mellitus
Larina I.I., Severina A.S., Shamkhalova M.S., Shestakova M.V.
Cardiorenal prognosis in kidney dysfunction patients undergoing cardiac surgery
Iskenderov B.G., Sisina O.N.
Hyperuricemia as a component of cardiorenal syndrome
Mukhin N.A., Fomin V.V., Lebedeva M.V., Mukhin N.A., Fomin V.V., Lebedeva M.V.
Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3–C5D chronic kidney disease
Dzgoeva F.U., Remizov O.V., Goloeva V.G., Ikoeva Z.R.
The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease
Mikhailova N.A.
Changes in metabolic parameters and glomerular filtration rate in patients with morbid obesity after bariatric surgery
Gussaova S.S., Bobkova I.N., Yashkov Y.I., Bordan N.S., Stavrovskaya E.V., Bekuzarov D.K., Evdoshenko V.V., Fedenko V.V., Malykhina A.I., Struve A.V.
Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up
Zemlyanskaya O.A., Kropacheva E.S., Dobrovolsky A.B., Panchenko E.P.
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease
Mukhin N.A., Milovanov Y.S., Kozlovskaya L.V., Dobrosmyslov I.A., Milovanova L.Y.
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease
Milovanova L.Y., Milovanov Y.S., Kudryavtseva D.V., Markina M.M., Milovanova S.Y., Kozlovskaya L.V., Lebedeva M.V., Beketov V.D., Moiseev S.V., Mukhin N.A., Fomin V.V., Svistunov A.A.
Chronic kidney disease and vascular dementia
Mukhin N.A., Fomin V.V., Damulin I.V., Rogova I.V.
Specific features of cognitive impairments in patients with predialysis chronic kidney disease
Rogova I.V., Fomin V.V., Damulin I.V., Shashkova E.V.
The pathogenetic bases of cardiorenal syndrome
Beloglazova I.P., Mogutova P.A., Poteshkina N.G.
Calcium antagonists: on the way to expanding the indications
Fomin V.V.
The role of balanced low-protein diet in inhibition of progression of predialysis chronic disease of the kidneys in systemic diseases
Milovanov Y.S., Lysenko L.V., Milovanova L.Y., Dobrosmyslov I.A., Milovanov Y.S., Lysenko L.V., Milovanova L.Y., Dobrosmyslov I.A.
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study
Batyushin M.M.
Low serum Klotho level as a predictor of calcification of the heart and blood vessels in patients with CKD stages 2–5D
Milovanova L.Y., Lysenko (Kozlovskaya) L.V., Milovanova S.Y., Taranova M.V., Kozlov V.V., Reshetnikov V.A., Lebedeva M.V., Androsova T.V., Zubacheva D.O., Chebotareva N.V.
Diabetes mellitus and chronic kidney disease: Possibilities of prediction, early diagnosis, and nephroprotection in the 21st century
Shestakova M.V.
Acute glomerulonephritis in the 21st century
Mukhin N.A., Glybochko P.V., Svistunov A.A., Fomin V.V., Shilov E.M., Lysenko L.V.
Risk factors for and prognostic value of multifocal atherosclerosis in patients with diabetes mellitus
Gracheva S.A., Biragova M.S., Glazunova A.M., Klefortova I.I., Shamkhalova M.S., Dzhavelidze M.I., Soldatova T.V., Il'in A.V., Shestakova M.V., Tugeeva É.F., Buziashvili I.I.
Risk factors for cardiovascular system damage in chronic kidney disease
Kutyrina I.M., Rudenko T.E., Savel'eva S.A., Shvetsov M.I., Vasil'eva M.P.
Obesity and chronic kidney disease
Bondar' I.A., Klimontov V.V., Simakova A.I., Bondar I.A., Klimontov V.V., Simakova A.I.
Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor 23 and Klotho
Milovanova L.Y., Kozlovskaya L.V., Milovanov Y.S., Bobkova I.N., Dobrosmyslov I.A.
Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B–4 stages of chronic kidney disease: prospective, randomized, controlled clinical study
Milovanova L.Y., Taranova M.V., Volkov A.V., Milovanova S.Y., Beketov V.D.
Diagnostic value of urinary biomarkers excretion in estimation of morphological lesions in patients with primary glomerulopathies
Saganova E.S., Zubina I.M., Bogdanova E.O., Galkina O.V., Sipovskii V.G., Smirnov A.V.
Low protein diet with essential amino acids ketoanalogues combination can affect serum FGF-23 and Klotho levels in chronic kidney disease 3b-4 stages patients: randomized pilot study
Milovanova L.Y., Kozlovskaya(Lysenko) L.V., Androsova T.V., Lebedeva M.V., Taranova M.V., Milovanova S.Y., Kondratyeva T.B., Zubacheva D.O., Tchebotareva N.V., Kozlov V.V., Kuchieva A.M., Li O.A., Reshetnikov V.A.
Urinary excretion of angiogenesis regulatory factors and renal injury markers in chronic glomerulonephritis: Significance in the assessment of progression
Shvetsov M.Y., Zheng A., Kozlovskaya L.V., Serova A.G., Travkina E.V., Mukhin N.A.
Hyperuricemia and the problem of chronic kidney disease
Shcherbak A.V., Kozlovskaia L.V., Bobkova I.N., Balkarov I.M., Lebedeva M.V., Stakhova T.I.
New markers of cardio-renal links in chronic kidney disease
Milovanova L.I., Milovanov I.S., Kozlovskaia L.V., Mukhin N.A.
Radionuclide evaluation of renal function in essential hypertensive patients with chronic kidney disease
Musina N.S., Semenova R.I.
THE ROLE OF HYPERINSULINEMIA AND INSULIN RESISTANCE IN DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME
Kutyrina I.M., Kryachkova A.A., Savelieva S.A.
The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients
Saginova E.A., Gallyamov M.G., Severova M.M., Surkova O.A., Fomin V.V., Ermakov N.V., Rodina A.V., Mukhin N.A., Saginova E.A., Gallyamov M.G., Severova M.M., Surkova O.A., Fomin V.V., Ermakov N.V., Rodina A.V., Mukhin N.A.
Autonomic imbalance in patients with metabolic syndrome: role in the development of hyperfiltration, an early marker of renal lesion
Gornostayeva E.Y., Novikova M.S., Beloborodova A.V., Akarachkova E.S., Shilov E.M., Shvarkov S.B.
Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5
Dzgoeva F.U., Remizov O.V., Botcieva V.K., Goloeva V.G., Malakhova N.G., Ikoeva Z.R.
Venous thromboembolic complications in patients with chronic kidney disease: prevalence and features of drug treatment
Dzhioeva O.N., Orlova A.A., Rogozhkina E.A., Drapkina O.M.
Diabetes epidemiology in Russia: what has changed over the decade?
Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Isakov M.A., Dedov I.I.
Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease
Rudenko T.E., Kamyshova E.S., Vasilyeva M.P., Bobkova I.N., Solomakhina N.I., Shvetsov M.Y.
Endothelial dysfunction and arterial wall stiffness: New targets in diabetic nephropathy
Murkamilov I.T., Sabirov I.S., Fomin V.V., Yusupov F.A.
The role of immune factors in the progression of chronic kidney diseases in HIV infection
Yushchuk N.D., Gadzhikulieva M.M., Balmasova I.P., Volgina G.V., Gultyaev M.M.
Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease
Dzgoeva F.U., Gatagonova T.M., Bestaeva T.L., Sopoev M.I., Bazaeva B.G., Khamitsaeva O.V.
Renal anemia and cardiac remodeling in patient with chronic glomerulonephritis
Murkamilov I.T., Lunegova O.S., Kaliev R.R.
1 - 86 of 86 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».